- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $259.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $183.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $173M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $239.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $882.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $897.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.41B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.36B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.42B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.39B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.27B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.24B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.88B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.88B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 148.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $74.5M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $47.3M |
| Capex | Q1 2025 · Mar 31, 2024 | $22M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $106.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $192.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $147.6M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $193.7M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $384.7M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $594.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $978.8M |